Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
patisiran
2
×
akcea therapeutics
alexion pharmaceuticals
alnylam pharmaceuticals
anylam pharmaceuticals
biotech
boehringer ingelheim
boston
cardiomyopathy
deals
dicerna pharamceuticals
drugs
fda
hepatitis b
hepatitis b virus
hereditary transthyretin amyloidosis
inotersen
neuropathy
new york
new york blog main
new york top stories
onpattro
pfizer
rna interference
roche
san diego blog main
san diego top stories
tafamidis
tegsedi
transthyretin amyloidosis
world health organization
What
disease
2
×
drug
medicines
ago
akcea
alnylam
amyloidosis
approved
attr
available
battle
caught
causing
debilitating
dicerna
eye
fda
gene
genetic
hepatitis
intended
oks
patients
pay
pfizer
pharma
pharmaceuticals
producing
protein
rare
research
roche
sets
stop
team
transthyretin
year
Language
unset
Current search:
patisiran
×
disease
×
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
